Back
Ironwood Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
IRWD
Sponsored
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
17
IRWD
Ironwood Pharmaceuticals
Last Price:
7.66
Seasonality Move:
1.02%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftlyIronwood Pharmaceuticals Price Quote
$7.66
+0.01 (+-2.85%)
(Updated: April 18, 2024 at 4:49 AM ET)
Ironwood Pharmaceuticals Key Stats
Sell
17
Ironwood Pharmaceuticals (IRWD)
is a Sell
Day range:
$7.64 - $7.94
52-week range:
$7.68 - $15.70
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.96
P/B ratio:
0%
Volume:
1.8M
Avg. volume:
4.5M
1-year change:
-31.88%
Market cap:
$1.2B
Revenue:
$442.7M
EPS:
$-6.51
How Much Does Ironwood Pharmaceuticals Make?
-
How Much Are Ironwood Pharmaceuticals's Sales Annually?
IRWD Revenues are $442.7M -
How Much Profit Does Ironwood Pharmaceuticals's Make A Year?
IRWD net income is -$1B
Is Ironwood Pharmaceuticals Growing As A Company?
-
What Is Ironwood Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.1% -
What Is Ironwood Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ironwood Pharmaceuticals Stock Price Performance
-
Did Ironwood Pharmaceuticals Stock Go Up Last Month?
Ironwood Pharmaceuticals share price went down by -15.19% last month -
Did IRWD's Share Price Rise Over The Last Year?
IRWD share price fell by -31.88% over the past 1 year
What Is Ironwood Pharmaceuticals 52-Week High & Low?
-
What Is Ironwood Pharmaceuticals’s 52-Week High Share Price?
Ironwood Pharmaceuticals has traded as high as $15.70 over the past 52 weeks -
What Is Ironwood Pharmaceuticals’s 52-Week Low Share Price?
Ironwood Pharmaceuticals has traded as low as $7.68 over the past 52 weeks
Ironwood Pharmaceuticals Price To Free Cash Flow
-
Is Ironwood Pharmaceuticals Stock Overvalued?
Ironwood Pharmaceuticals is trading at a price to free cash flow ratio of 7.16 -
Is Ironwood Pharmaceuticals Stock Undervalued?
Ironwood Pharmaceuticals EV to Free Cash Flow ratio is 10.05 -
What Is Ironwood Pharmaceuticals’s Price Earnings Growth Ratio?
IRWD PEG ratio is 0.00 -
Is Ironwood Pharmaceuticals Trading At A Premium To Earnings?
Ironwood Pharmaceuticals EV to EBIT ratio is 0.00
Is It Risky To Buy Ironwood Pharmaceuticals?
-
How Much Debt Does Ironwood Pharmaceuticals Have?
Total long term debt quarterly is $697.9M -
How Much Cash Does Ironwood Pharmaceuticals Have?
Cash and short term investments quarterly total is $92.2M -
What Is Ironwood Pharmaceuticals’s Book Value Per Share?
Book value per share is -2.21
Is Ironwood Pharmaceuticals Cash Flow Positive?
-
What Is IRWD Cash Flow From Operations?
Cash flow from operations (TTM) is $183.4M -
What Is Ironwood Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $277.2M -
What Is Ironwood Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1B
Ironwood Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
IRWD return on invested capital is -149.55% -
What Is Ironwood Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -130.02% -
What Is IRWD Return On Equity?
ROE is a measure of profitability and is -1471.81%
Ironwood Pharmaceuticals Earnings Date & Stock Price
-
What Is Ironwood Pharmaceuticals's Stock Price Today?
A single share of IRWD can be purchased today for 7.65 -
What Is Ironwood Pharmaceuticals’s Stock Symbol?
Ironwood Pharmaceuticals trades on the nasdaq under the ticker symbol: IRWD -
When Is Ironwood Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Ironwood Pharmaceuticals is scheduled on May 3, 2024 -
When Is IRWD's next ex-dividend date?
Ironwood Pharmaceuticals's next ex-dividend date is May 16, 2020 -
How To Buy Ironwood Pharmaceuticals Stock?
You can buy Ironwood Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ironwood Pharmaceuticals Competitors
-
Who Are Ironwood Pharmaceuticals's Competitors?
Below is a list of companies who compete with Ironwood Pharmaceuticals or are related in some way:
Ironwood Pharmaceuticals Dividend Yield
Data Unavailable
Ironwood Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -100% |
Revenue: | 9.66% | 0.13% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 18.00 |
Upside from Last Price: | 135.29% |